Medi Caps Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve 1.Consider and approve the Standalone as well as Consolidated Un-Audited Financial Results of the Company for the quarter and half year ended on 30th September, 2026 along with limited review report thereon. 2.Consider other routine matters as may be considered necessary with the permission of chair.

MEDI-CAPS LIMITED CIN: L70100MP1983PLC002231 MCL/BM/SE/2026-2027 Date: 28.10.2026 Online filing at: www.listing.bseindia.com The General Manager, DCS-CRD BSE Limited Rotunda Building, P.J. Tower, Dalal Street, Fort Mumbai - 400001 Subject: Intimation for meeting of Board of Directors (Serial No. 03/2026-27) of the Company, scheduled to be held on Wednesday, 04th day of November, 2026 pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. REFERENCE: MEDI-CAPS LIMITED (BSE Scrip Code: 523144, ISIN: INE442D01010) Dear Sir/Madam, With reference to the above mentioned subject and in terms of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that the Meeting (03/2026-2027) of the Board of Directors of the Company is scheduled to be held on Wednesday, 04th day of November, 2026 at the Registered Office of the Company situated at 201, Pushpratna Paradise, 9/5 New Palasiya, Indore (M.P.) 452001 to inter-alia: 1. Consider and approve the Standalone as well as Consolidated Un-Audited Financial Results of the Company for the quarter and half year ended on 30th September, 2026 along with limited review report thereon. 2. Consider other routine matters as may be considered necessary with the permission of chair. Further, we are submitting the above said information in XBRL mode (excel template provided by Exchange) along with the submission in PDF mode within prescribed time limit. Further, in continuation to earlier disclosure dated 25.09.2026, pursuant to Company’s code of conduct to regulate, monitor and report trading in Company’s Securities by Insiders framed under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, Trading Window for dealing in the securities of the Company shall open after 48 hours of declaration of Standalone and consolidated Un-Audited Financial Results for the quarter and half year ended 30th September, 2026 for all designated persons, their immediate relatives and all connected persons covered under the aforesaid code. You are requested to please take on record the above said information for your reference and further needful and disseminate on the website of the BSE. Thanking you, Yours faithfully, FOR, MEDI-CAPS LIMITED ABHISHEK JAIN COMPANY SECRETARY & COMPLIANCE OFFICER M. No. A36699 REGISTERED OFFICE 201, PUSHPRATNA PARADISE, 9/5 NEW PALASIYA INDORE – 452001 PH:- 0731-4028148, FAX:- 0731-4041435 E mail:- investors@medicaps.com, Web site:- www.medicaps.com